Jane Street Group, LLC Mereo Biopharma Group PLC Transaction History
Jane Street Group, LLC
- $444 Billion
- Q4 2024
A detailed history of Jane Street Group, LLC transactions in Mereo Biopharma Group PLC stock. As of the latest transaction made, Jane Street Group, LLC holds 120,278 shares of MREO stock, worth $304,303. This represents 0.0% of its overall portfolio holdings.
Number of Shares
120,278
Previous 214,635
43.96%
Holding current value
$304,303
Previous $882,000
52.38%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding MREO
# of Institutions
99Shares Held
116MCall Options Held
151KPut Options Held
455K-
Janus Henderson Group PLC London, X017.1MShares$43.3 Million0.03% of portfolio
-
Rubric Capital Management LP New York, NY15.3MShares$38.7 Million0.89% of portfolio
-
Rock Springs Capital Management LP Baltimore, MD9.6MShares$24.3 Million1.34% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA8.72MShares$22 Million0.06% of portfolio
-
Mangrove Partners New York, NY8.64MShares$21.9 Million4.71% of portfolio
About Mereo Biopharma Group plc
- Ticker MREO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 124,986,000
- Market Cap $316M
- Description
- Mereo BioPharma Group plc, a biopharmaceutical company, develops and commercializes therapeutics for the treatment of oncology and rare diseases in the United Kingdom and internationally. Its lead product candidate, etigilimab (OMP-313M32), an antibody T-cell immunoreceptor with Ig and ITIM domains, which is in Phase 1b clinical trial for the tr...